Cargando…

Acute pharmacotherapy of migraine, tension-type headache, and cluster headache

In most migraine patients acute therapy is needed. Migraine can be treated either with specific drugs, the triptans and ergot alkaloids, or with NSAIDs. Triptans are a major step foreward in migraine therapy. The therapeutic gain for headache relief is 50% for subcutaneous sumatriptan whereas it is...

Descripción completa

Detalles Bibliográficos
Autor principal: Tfelt-Hansen, Peer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476138/
https://www.ncbi.nlm.nih.gov/pubmed/17497267
http://dx.doi.org/10.1007/s10194-007-0373-z
_version_ 1782247056721575936
author Tfelt-Hansen, Peer
author_facet Tfelt-Hansen, Peer
author_sort Tfelt-Hansen, Peer
collection PubMed
description In most migraine patients acute therapy is needed. Migraine can be treated either with specific drugs, the triptans and ergot alkaloids, or with NSAIDs. Triptans are a major step foreward in migraine therapy. The therapeutic gain for headache relief is 50% for subcutaneous sumatriptan whereas it is 30-40% for most oral triptans. After oral triptans sustained pain free is only 30%. There is thus still ample room for improvement of acute therapy in migraine. For tension-type headache there is no specific therapy and it is treated with NSAIDs. Only 17-32% become pain free after these drugs. For attacks of cluster headache oxygen and subcutaneous sumatriptan can be used. Intranasal triptans can be an alternative.
format Online
Article
Text
id pubmed-3476138
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-34761382012-11-29 Acute pharmacotherapy of migraine, tension-type headache, and cluster headache Tfelt-Hansen, Peer J Headache Pain Tutorial In most migraine patients acute therapy is needed. Migraine can be treated either with specific drugs, the triptans and ergot alkaloids, or with NSAIDs. Triptans are a major step foreward in migraine therapy. The therapeutic gain for headache relief is 50% for subcutaneous sumatriptan whereas it is 30-40% for most oral triptans. After oral triptans sustained pain free is only 30%. There is thus still ample room for improvement of acute therapy in migraine. For tension-type headache there is no specific therapy and it is treated with NSAIDs. Only 17-32% become pain free after these drugs. For attacks of cluster headache oxygen and subcutaneous sumatriptan can be used. Intranasal triptans can be an alternative. Springer-Verlag 2007-05-11 2007-04 /pmc/articles/PMC3476138/ /pubmed/17497267 http://dx.doi.org/10.1007/s10194-007-0373-z Text en © Springer-Verlag Italia 2007
spellingShingle Tutorial
Tfelt-Hansen, Peer
Acute pharmacotherapy of migraine, tension-type headache, and cluster headache
title Acute pharmacotherapy of migraine, tension-type headache, and cluster headache
title_full Acute pharmacotherapy of migraine, tension-type headache, and cluster headache
title_fullStr Acute pharmacotherapy of migraine, tension-type headache, and cluster headache
title_full_unstemmed Acute pharmacotherapy of migraine, tension-type headache, and cluster headache
title_short Acute pharmacotherapy of migraine, tension-type headache, and cluster headache
title_sort acute pharmacotherapy of migraine, tension-type headache, and cluster headache
topic Tutorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476138/
https://www.ncbi.nlm.nih.gov/pubmed/17497267
http://dx.doi.org/10.1007/s10194-007-0373-z
work_keys_str_mv AT tfelthansenpeer acutepharmacotherapyofmigrainetensiontypeheadacheandclusterheadache